Breast Carcinoma
Conditions
Keywords
breast cancer, Quran recital, life of quality, sleep of quality
Brief summary
Objective: This study aims to investigate the effects of Quran on quality of life and sleep in patients receiving chemotherapy due to breast cancer. Method: This study will be conducted with 40 patients with breast cancer receiving chemotherapy at Erzurum City Hospital Outpatient Chemotherapy Unit in a randomized controlled experimental design. Block randomization will be used in group assignment. The breast cancer patient identification form, European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30) and Pittsburg Sleep Quality Index (PSQI) will be used to collect research data. It is planned to collect research data with a total of four measurements during the application of the first, second, third and last protocols of chemotherapy. Expected Results: As a result of the study, it is expected that Quran recitation will have a positive effect on quality of life and sleep in patients receiving chemotherapy due to breast cancer.
Interventions
OTHERstandard treatment and care
standard treatment and care
BEHAVIORALQuran recital
standard treatment and care
Sponsors
Erzurum Technical University
Ardahan University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
Before the study, a separate consent form was prepared for the experimental group and a separate consent form for the control group, and it was planned to blind the participants by not informing them about which group they were in. In addition, data will be entered with group 1 and group 2 coding for the Quran recital group and the control group, and it was planned to apply statistician blinding.
Intervention model description
randomized controlled design
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Having breast cancer * Being on chemotherapy * Being on a chemotherapy protocol every 21 days * Being over the age of 18 * Not having communication problems * Being willing to participate in the study
Exclusion criteria
* Having a hearing problem * Having an ear infection or any condition that prevents hearing * Having other types of cancer other than breast cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30), Version 3.0 (EORTC QLQ C-30) | From registration to the end of treatment at week 12 | The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30), Version 3.0 (EORTC QLQ C-30) will be used to assess quality of life. High general well-being and functional subscale scores indicate high quality of life. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pittsburg Sleep Quality Index | From registration to the end of treatment at week 12 | The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality. A score of six or above indicates poor sleep quality. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactDerya ŞİMŞEKLİ
Backup ContactBedriye Cansu KOYUNOĞLU
Outcome results
None listed